New, wildly effective weight loss drugs have made the first real, mainstream inroads in the fight against obesity. The economic and financial implications are staggering – and the potential impact on the travel sector could be seismic.
The introduction of effective weight loss drugs, such as GLP-1s, is transforming the obesity landscape and could have a significant impact on the travel industry. While airlines and active travel experience providers stand to benefit from lighter passengers and increased demand, respectively, businesses reliant on food and beverage revenue, like restaurants, may face challenges. Additionally, the rise in weight loss could lead to increased passport renewals due to significant changes in personal appearance.
Subscribe now for complete access to Skift.com's trusted coverage of the travel industry.
Already a subscriber? Login